Anti-nephrin autoantibodies are associated with disease activity in MCD, exhibit an IgG4-predominant subclass, and are accompanied by a Th2-skewed cytokine profile. These findings suggest their potential as a noninvasive biomarker, warranting further prospective studies to validate their clinical utility.
Guo et al. (Wed,) studied this question.